US Stock MarketDetailed Quotes

THRD Third Harmonic Bio

Watchlist
  • 12.150
  • -0.010-0.08%
Trading Jul 24 12:11 ET
497.54MMarket Cap-15000P/E (TTM)

Third Harmonic Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-5.82%11.29M
16.56%43.95M
-23.21%10.41M
26.30%10.85M
37.66%10.71M
53.95%11.99M
98.42%37.71M
135.61%13.55M
50.75%8.59M
7.78M
Selling and administrative expenses
-3.56%5.06M
50.29%19.99M
4.52%4.49M
27.33%4.88M
49.19%5.37M
233.40%5.25M
308.51%13.3M
192.84%4.29M
391.15%3.83M
--3.6M
-General and administrative expense
-3.56%5.06M
50.29%19.99M
4.52%4.49M
27.33%4.88M
49.19%5.37M
233.40%5.25M
308.51%13.3M
192.84%4.29M
391.15%3.83M
--3.6M
Research and development costs
-7.58%6.23M
-1.82%23.96M
-36.07%5.92M
25.48%5.97M
27.72%5.34M
8.45%6.74M
54.98%24.41M
116.03%9.26M
-3.25%4.76M
--4.18M
Operating profit
5.82%-11.29M
-16.56%-43.95M
23.21%-10.41M
-26.30%-10.85M
-37.66%-10.71M
-53.95%-11.99M
-98.42%-37.71M
-135.61%-13.55M
-50.75%-8.59M
-7.78M
Net non-operating interest income expense
18.18%3.43M
413.03%13.11M
73.38%3.58M
806.01%3.47M
2,851.40%3.16M
2.91M
2.56M
2.06M
383K
107K
Non-operating interest income
18.18%3.43M
413.03%13.11M
73.38%3.58M
806.01%3.47M
2,851.40%3.16M
--2.91M
--2.56M
--2.06M
--383K
--107K
Other net income (expense)
150.00%1K
1,200.00%22K
-6K
34K
-4K
-166.67%-2K
99.98%-2K
Other non- operating income (expenses)
150.00%1K
1,200.00%22K
---6K
--34K
---4K
-166.67%-2K
99.98%-2K
----
----
----
Income before tax
13.53%-7.86M
12.32%-30.82M
40.50%-6.84M
10.51%-7.34M
1.51%-7.56M
-16.71%-9.09M
-18.73%-35.16M
27.20%-11.49M
-11.16%-8.21M
-7.68M
Income tax
Net income
13.53%-7.86M
12.32%-30.82M
40.50%-6.84M
10.51%-7.34M
1.51%-7.56M
-16.71%-9.09M
-18.73%-35.16M
27.20%-11.49M
-11.16%-8.21M
-7.68M
Net income continuous Operations
13.53%-7.86M
12.32%-30.82M
40.50%-6.84M
10.51%-7.34M
1.51%-7.56M
-16.71%-9.09M
-18.73%-35.16M
27.20%-11.49M
-11.16%-8.21M
---7.68M
Minority interest income
Net income attributable to the parent company
13.53%-7.86M
12.32%-30.82M
40.50%-6.84M
10.51%-7.34M
1.51%-7.56M
-16.71%-9.09M
-18.73%-35.16M
27.20%-11.49M
-11.16%-8.21M
-7.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.53%-7.86M
12.32%-30.82M
40.50%-6.84M
10.51%-7.34M
1.51%-7.56M
-16.71%-9.09M
-18.73%-35.16M
27.20%-11.49M
-11.16%-8.21M
-7.68M
Basic earnings per share
13.04%-0.2
68.16%-0.78
41.74%-0.17
78.89%-0.19
8.93%-0.19
-8.72%-0.23
-204.45%-2.45
31.97%-0.2918
-348.65%-0.9
-0.2086
Diluted earnings per share
13.04%-0.2
68.16%-0.78
41.74%-0.17
78.89%-0.19
8.93%-0.19
-8.72%-0.23
-204.45%-2.45
31.97%-0.2918
-348.65%-0.9
-0.2086
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -5.82%11.29M16.56%43.95M-23.21%10.41M26.30%10.85M37.66%10.71M53.95%11.99M98.42%37.71M135.61%13.55M50.75%8.59M7.78M
Selling and administrative expenses -3.56%5.06M50.29%19.99M4.52%4.49M27.33%4.88M49.19%5.37M233.40%5.25M308.51%13.3M192.84%4.29M391.15%3.83M--3.6M
-General and administrative expense -3.56%5.06M50.29%19.99M4.52%4.49M27.33%4.88M49.19%5.37M233.40%5.25M308.51%13.3M192.84%4.29M391.15%3.83M--3.6M
Research and development costs -7.58%6.23M-1.82%23.96M-36.07%5.92M25.48%5.97M27.72%5.34M8.45%6.74M54.98%24.41M116.03%9.26M-3.25%4.76M--4.18M
Operating profit 5.82%-11.29M-16.56%-43.95M23.21%-10.41M-26.30%-10.85M-37.66%-10.71M-53.95%-11.99M-98.42%-37.71M-135.61%-13.55M-50.75%-8.59M-7.78M
Net non-operating interest income expense 18.18%3.43M413.03%13.11M73.38%3.58M806.01%3.47M2,851.40%3.16M2.91M2.56M2.06M383K107K
Non-operating interest income 18.18%3.43M413.03%13.11M73.38%3.58M806.01%3.47M2,851.40%3.16M--2.91M--2.56M--2.06M--383K--107K
Other net income (expense) 150.00%1K1,200.00%22K-6K34K-4K-166.67%-2K99.98%-2K
Other non- operating income (expenses) 150.00%1K1,200.00%22K---6K--34K---4K-166.67%-2K99.98%-2K------------
Income before tax 13.53%-7.86M12.32%-30.82M40.50%-6.84M10.51%-7.34M1.51%-7.56M-16.71%-9.09M-18.73%-35.16M27.20%-11.49M-11.16%-8.21M-7.68M
Income tax
Net income 13.53%-7.86M12.32%-30.82M40.50%-6.84M10.51%-7.34M1.51%-7.56M-16.71%-9.09M-18.73%-35.16M27.20%-11.49M-11.16%-8.21M-7.68M
Net income continuous Operations 13.53%-7.86M12.32%-30.82M40.50%-6.84M10.51%-7.34M1.51%-7.56M-16.71%-9.09M-18.73%-35.16M27.20%-11.49M-11.16%-8.21M---7.68M
Minority interest income
Net income attributable to the parent company 13.53%-7.86M12.32%-30.82M40.50%-6.84M10.51%-7.34M1.51%-7.56M-16.71%-9.09M-18.73%-35.16M27.20%-11.49M-11.16%-8.21M-7.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.53%-7.86M12.32%-30.82M40.50%-6.84M10.51%-7.34M1.51%-7.56M-16.71%-9.09M-18.73%-35.16M27.20%-11.49M-11.16%-8.21M-7.68M
Basic earnings per share 13.04%-0.268.16%-0.7841.74%-0.1778.89%-0.198.93%-0.19-8.72%-0.23-204.45%-2.4531.97%-0.2918-348.65%-0.9-0.2086
Diluted earnings per share 13.04%-0.268.16%-0.7841.74%-0.1778.89%-0.198.93%-0.19-8.72%-0.23-204.45%-2.4531.97%-0.2918-348.65%-0.9-0.2086
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg